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OBJECTIVE — The purpose of this study was to provide the ﬁrst national estimate on the
prevalence of the metabolic syndrome and its components and the ﬁrst ethnic-speciﬁc cutoff
point for waist circumference in the Eastern Mediterranean Region.
RESEARCH DESIGN AND METHODS — This national survey was conducted in 2007
on 3,024 Iranians aged 25–64 years living in urban and rural areas of all 30 provinces in Iran.
The metabolic syndrome was deﬁned by different criteria, namely the deﬁnition of the National
Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III), the International
Diabetes Federation (IDF) criteria, and the modiﬁed deﬁnition of the NCEP/ATP III (ATP
III/American Heart Association [AHA]/National Heart, Lung, and Blood Institute [NHLBI]).
RESULTS — The age-standardized prevalence of the metabolic syndrome was about 34.7%
(95% CI 33.1–36.2) based on the ATP III criteria, 37.4% (35.9–39.0%) based on the IDF
deﬁnition, and 41.6% (40.1–43.2%) based on the ATP III/AHA/NHLBI criteria. By all deﬁni-
tions,theprevalenceofthemetabolicsyndromewashigherinwomen,inurbanareas,andinthe
55- to 64-year age-group compared with the prevalence in men, in rural areas, and in other
age-groups, respectively. The metabolic syndrome was estimated to affect 11 million Iranians.
The optimal cutoff point of waist circumference for predicting at least two other components of
the metabolic syndrome as deﬁned by the IDF was 89 cm for men and 91 cm for women.
CONCLUSIONS — The high prevalence of the metabolic syndrome with its considerable
burden on the middle-aged population mandates the implementation of national policies for its
prevention, notably by tackling obesity. The waist circumference cutoff points obtained can be
used in the region.
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D
espite the rapidly growing preva-
lence of chronic noncommunicable
diseases in developing countries,
notably in Asians with an ethnic predis-
position to insulin resistance and adverse
body fat patterning seen in the metabolic
syndrome (1), limited data exist on na-
tional estimates of such disorders. In this
context, the rapid epidemiological transi-
tioninMiddleEasterncountriesisacause
of concern. These nations have the high-
est dietary energy surplus of all develop-
ing countries (2) and one of the highest
prevalence rates of overweight (3); the re-
gion is expected to show one of the
world’s greatest increases in the absolute
burden of diabetes in the next two de-
cades (4). Meanwhile there are no na-
tional data either on the distribution of
the metabolic syndrome and its compo-
nents or on the ethnic-speciﬁc optimal
thresholds for waist circumference in this
region. Our aim in this study was to esti-
mate the national prevalence of the meta-
bolic syndrome based on three sets of
criteria and to determine the optimal cut-
off point of waist circumference based on
matching with other components of the
metabolic syndrome in the Middle East.
RESEARCH DESIGN AND
METHODS— ThethirdNationalSur-
vey of Risk Factors of Non-Communica-
ble Diseases (SURFNCD 2007) was a
population-based nationwide health sur-
vey conducted in Iran using guidelines of
the STEPwise approach to noncommuni-
cablediseaseriskfactorsurveillanceofthe
World Health Organization (WHO) (5)
with some modiﬁcations (6). The sample
size was calculated as 384 in each age and
sex group and was increased to 500 be-
cause the cluster sampling method was
used; 250 clusters, each with 20 individ-
uals, were selected in each sex and age-
group. We recruited individuals from the
households in a cluster using a quota ap-
proach, but we avoided recruiting sub-
jects from the same age-group in a single
household.
The population aged 25 years was
eligible for blood sampling and consisted
of 4,000 individuals. Using a probability
proportional to size multistage cluster
random sampling method, a stratiﬁed
representative sample of the population
intheurbanandruralareasofall30prov-
inces of the country was studied. The
Center for Disease Control and Manage-
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written consent was obtained from
participants.
Data collection
Strict training modules were designed
and used to train interviewers and other
staff. A vigorous quality assurance pro-
gram was implemented to ensure the
quality of data collection and laboratory
examinations. After selecting the eligible
individuals, all steps were done at the
door. A team consisting of health care
professionals recorded demographic and
health information in a checklist and car-
ried out the ﬁeld examinations by stan-
dardized and calibrated instruments.
Weight, height, and waist circumference
were measured according to a standard
protocol (5), and BMI was computed.
Blood pressure was measured three times
by using a digital sphygmomanometer
(M7 Omron). The means of the second
and third measurements were used in the
analysis.
Trained laboratory technicians ob-
tainedfasting(10–12h)venousbloodsam-
plesandtransferredthemincoldboxestoa
referrallaboratoryineachprovincethatwas
at most 4 h away from the sampling site. In
addition, for protecting blood glucose con-
centrations from glycolysis, the anticoagu-
lant sodium ﬂuoride was added to the
collectionvial.Thebloodsampleswerecen-
trifuged, and sera were kept frozen at
20°C before being transferred to the Na-
tional Reference Laboratory, a WHO-
collaborating center in Tehran. We
measuredglucosewiththeglucoseoxidase/
peroxidase-4-aminophenazone-phenol
method and triglycerides were measured
using glycerol-3-phosphate oxidase-
peroxidase aminophenazone (Randox).
HDL cholesterol was determined after dex-
tran sulfate-magnesium chloride precipita-
tion of non–HDL cholesterol (7). Uniform
testing kits from the same batch number
(Pars Azmoun Company) were used to test
the samples. Of all samples, 10% were re-
checked by the National Reference Labora-
tory as a quality assurance measure. The
coefﬁcient of variation was 5% for all lab-
oratory measurements.
Deﬁnitions and criteria for
metabolic syndrome
We used the 2001 criteria of the National
Cholesterol Education Program (NCEP)
Adult Treatment Panel III (ATP III) (8),
the 2005 criteria of the International Dia-
betes Federation (IDF) (9), and the deﬁ-
nition of the NCEP ATP III modiﬁed in
2005 by the American Heart Association
(AHA) and the National Heart, Lung, and
Blood Institute (NHLBI) (10).
Statistical methods
Stata statistical software (release 9.1,
StataCorp, College Station, TX) was used
for analysis with complex sample survey
modules and commands. Variables of
provinces were the indicators of strata,
and in each province there were a few
clusters from which participants were re-
cruited. Because the sampling was based
on studying two individuals of each sex
anda10-yearspanwithineveryrandomly
selected cluster, we used age and sex
strata for poststratiﬁcation and standard-
ization for the Iranian population. Stan-
dardization was achieved by determining
community size in the provinces and ru-
ral/urban areas represented by each par-
ticipant in the study. These weights made
the standardized results that can be gen-
eralizedtotheIranianpopulationaged25
to 64 years according to the 2007 Na-
tional Census. Continuous variables are
described by mean  SEM. For categori-
cal data and abnormal levels of variables
studied, the prevalence of abnormal cases
with conﬁdence intervals is reported.
The receiver operator characteristic
curve for waist circumference to present
at least two other components of the met-
abolic syndrome as deﬁned by the IDF
criteria (9) was plotted. The optimal cut-
offvaluesofwaistcircumferencewerecal-
culated by plotting the true positive rate
(sensitivity) against the false-positive rate
(1  speciﬁcity), when maximum accu-
racy (sensitivity plus speciﬁcity) was
achieved. To be able to compare our re-
sults with those from other countries in
theEasternMediterraneanRegion(EMR),
the ﬁndings were also directly standard-
ized with the WHO world standard pop-
ulation (11).
RESULTS— Of 4,000 target partici-
pants, 3,864 responded to interviews and
3,455 agreed to give blood samples. On
the whole, data obtained from interviews
and laboratory tests of 3,024 participants
(i.e.,75%ofthedesirednumberand79%
of the recruited population) were com-
plete and were included in the analysis.
The 20% of participants who had
dropped out in the laboratory phase were
fromdifferentage-groupsandsexgroups;
Table 1—Characteristics of participants by sex and living area
Men Women
Total Urban Rural Total Urban Rural
n 1,431* 942 489 1,535 1,003 532
Age (years) 41.5  0.07 41.5  0.1 41.6  0.1 41.2  0.07 41.0  0.1 41.3  0.8
SBP (mmHg) 124.7  0.3 126.6  0.4† 122.4  0.5† 123.7  0.5 123.5  0.9† 124.07  0.4†
DBP (mmHg) 80.0  0.4‡ 82.2  0.7†‡ 77.3  0.4†‡ 82.4  0.4‡ 82.1  0.7†‡ 82.7  0.3†‡
Weight (kg) 74.3  0.3 79.9  0.4 71.1  0.6 67.8  0.3 70.6  0.4 64.6  0.3
Height (cm) 169.6  0.2 171.0  0.2 167.9  0.3 156.4  0.2 157.1  0.3 155.5  0.2
BMI (kg/m
2) 25.6  0.1 26.3  0.1† 24.9  0.2† 27.8  0.1 28.7  0.2† 26.8  0.2†
Waist circumference (cm) 89.8  0.3 91.5  0.4 87.7  0.4 89.0  0.3 90.4  0.4 87.3  0.4
Total cholesterol (mmol/l) 4.99  5.2 5.05  0.04 4.93  0.03 5.24  5.2 5.23  0.03 5.25  0.03
LDL cholesterol (mmol/l) 3.27  0.02 3.28  0.03 3.25  0.02 3.45  0.02 3.41  0.03 3.50  0.03
HDL cholesterol (mmol/l) 0.89  0.01 0.85  0.01 0.97  0.01 1.03  0.01 1.00  0.01 1.06  0.01
Triglycerides (mmol/l) 1.84  0.03 2.00  0.05 1.64  0.03 1.66  0.02 1.90  0.03 1.50  0.03
Fasting blood glucose (mmol/l) 5.22  0.05‡ 5.42  0.08†‡ 4.99  0.03†‡ 5.09  0.04‡ 5.11  0.05†‡ 5.08  0.05†‡
Data are means  SEM. *Number of participants who have nonmissing values for all variables; number of valid cases for each variable may slightly differ. †P  0.05
for urban versus rural area. ‡P  0.05 for men versus women. DBP, diastolic blood pressure; SBP, systolic blood pressure.
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and the minority were older women.
Prevalence was estimated for nonmissing
cases and standardized to the Iran popu-
lation. In each stratum, the missing pat-
tern seems random and is not conﬁned to
special places or attributes. Although
some differences existed in various age-
groups and sex groups, as poststratiﬁca-
tion was done with real weights, the ﬁnal
estimates are not biased by the imbalance
ofthegroups.Participantswerelostinthe
laboratory stage mainly because some
standard transportation and sampling
procedures were not followed; in addi-
tion, codes assigned to some patients
were lost, and the patients could not be
matched to their corresponding results.
We studied 3,024 individuals with a
mean  SEM age of 41.3  0.07 years,
living in urban and rural areas of all 30
provincesofIran.Abouttwo-thirdsofthe
population were urban residents. Mean
systolic and diastolic blood pressure and
fasting plasma glucose (FPG) in urban
residents were higher than those in rural
residents (Table 1).
Overweight was documented in
34.2% of the population with a higher
prevalenceinwomenthaninmen(36.1%
vs. 32.1%, respectively, P  0.001).
Overall, 25.1% of the population studied
was obese, with a higher prevalence in
women than in men (33.3% vs. 17.2%,
respectively, P  0.0001). In both sexes,
overweight and obesity were more preva-
lent in urban areas than in rural areas
(data not shown).
The age-standardized prevalence of
themetabolicsyndromewas35.6%based
on the ATP III criteria (8), 37.4% by the
IDF deﬁnition (9), and 42.3% according
to the ATP III/AHA/NHLBI criteria (10).
By all deﬁnitions, the prevalence of the
metabolic syndrome in women and in the
55- to 64-year age-group was higher than
those in men and in other age-groups, re-
spectively. The increase in the prevalence
of metabolic syndrome with age had a
higher slope in women than in men, with
a 20% difference between men and
womeninthe25-to34-yearage-groupby
the ATP III criteria (8), increasing to
75% in the 55- to 64-year age-group.
Theestimatedprevalenceofthemetabolic
syndrome was consistently higher based
on the IDF deﬁnition (9) compared with
the ATP III (8) and ATP III/AHA/NHLBI
(10) criteria (Table 2).
Regardless of the deﬁnition used (8–
10), the prevalence of the metabolic syn-
drome in the urban population was 30–
100% higher than that in the rural
population. The prevalence of the meta-
bolic syndrome in the urban versus rural
population by the ATP III deﬁnition, the
IDF criteria (9), and the ATP III/AHA/
NHLBI criteria (10) was 42.1% (range
39.6–44.5%) versus 28.1% (26.4–
29.7%), 43.1% (40.7–45.5%) versus
30.9% (29.1–32.7%), and 49.5% (47.0-
51.9%) versus 33.8% (32.1–35.6%), re-
spectively (P  0.0001 for all differences).
By all sets of criteria used (8–10), the
most common component of the meta-
bolic syndrome was low serum HDL cho-
lesterol, found in 80% of the population.
Halfofthepopulationhadincreasedwaist
circumference, and more than one-third
had high serum triglyceride levels and high
blood pressure. FPG levels 110 mg/dl
were found in 12% and levels 100 mg/dl
in 16% of individuals (Table 3).
We estimated the burden of the met-
abolic syndrome for the Iranian popula-
tion aged 25–64 years. According to the
national census, in 2007 this population
consisted of 15,900,331 men and
15,479,406 women. Based on the ATP III
criteria (8), the metabolic syndrome
affected 4,574,352 men (95% CI
4,301,254–4,847,450) and 6,621,786
women (6,260,567–6,983,008). The es-
timates based on the IDF deﬁnition (9)
were 4,375,044 (4,301,254–4,847,450)
for men and 7,412,998 (7,060,598–
7,765,397) for women, and based on the
ATP III/AHA/NHLBI criteria (10) they
were 5,766,897 (5,477,624–6,056,171)
for men and 7,514,809 (7,151,077–
7,878,541) for women.
The optimal cutoff point of waist cir-
cumference for predicting at least two
other components of the metabolic syn-
drome as deﬁned by the IDF (9) was 88
cmformenand91cmforwomen(Fig.1).
When standardized with the WHO
world standard population (11), the esti-
mates of metabolic syndrome in the EMR
were 36.2% (95% CI 34.6–37.8) based
on the ATP III criteria (8), 39.2% (37.6–
40.9) based on the IDF criteria (9), and
44.6% (42.9–46.3) based on the ATP III/
AHA/NHLBI criteria (10). By the same
calculation, the regional estimates were
36.5% (34.7–38.2) for overweight,
24.3% (22.8–25.8) for generalized obe-
sity, and 36.9% (35.4–38.4) for abdomi-
nal obesity based on the ATP III criteria
(8), and 57.2% (55.6–58.8) based on the
IDF (9) and ATP III/AHA/NHLBI criteria
(10). Because the cluster effect was not
considered in standardization, these CIs
are slightly underestimated.
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1094 DIABETES CARE, VOLUME 32, NUMBER 6, JUNE 2009CONCLUSIONS — In this ﬁrst na-
tionally representative study of the bur-
den of the metabolic syndrome in the
Middle East, we found alarming preva-
lence rates of the syndrome and its com-
ponents as deﬁned by different sets of
criteria. This ﬁnding may be accounted
for by the rapid epidemiological, demo-
graphic, and nutritional transition in the
Iraniancommunity.Inaddition,although
the optimal cutoff points of waist circum-
ference for predicting other components
of the metabolic syndrome in the Iranian
population were similar in both sexes, in
men they were lower and in women they
were higher than the Europid cutoff
points currently recommended for use
with the Middle Eastern populations (9).
Our study of the burden of the metabolic
syndrome, which in turn inﬂuences the
risk of chronic diseases, provides up-to-
dateevidence-baseddatathatcanbeused
to orient the health systems of Middle
Eastern countries toward prevention and
early control of modiﬁable factors related
to clustering of risk factors in this region.
Limited experience exists regarding
theprevalenceofthemetabolicsyndrome
in the EMR. In a study in Tunisia, this
prevalence was 45.5% based on the IDF
criteria (9) and 24.3% according to the
ATP III deﬁnition (8), with signiﬁcantly
higherprevalenceinwomenthaninmen.
The two most common components were
increased waist circumference and low
HDL cholesterol (12). A survey in Turkey
reported a prevalence of 33.9% for meta-
bolic syndrome (8), with a higher preva-
lence in women (39.6%) than in men
(28%) (13). Another study in Turkey re-
ported a prevalence of 10.09 and 27.33%
for the metabolic syndrome in men and
women, respectively (14).
It is well documented that Asians
have an ethnic predisposition to adverse
body fat distribution and metabolic syn-
drome (1); hence, optimal cutoff points
for waist circumference have been estab-
lished for South Asians (9); by using this
cutoff, the prevalence of the metabolic
syndrome in this population is estimated
Figure 1—A: Men: receiver operator characteristic (ROC) curves for waist circumference to
predictthepresenceofatleasttworiskfactorsofthemetabolicsyndrome,asdeﬁnedbytheIDFfor
men.AreaunderROCcurve0.69.B:Women:theROCcurvesforwaistcircumferencetopredict
the presence of at least two risk factors of the metabolic syndrome, as deﬁned by the IDF for
women. Area under ROC curve  0.69.
Table 3—Prevalence of the metabolic syndrome components based on different sets of criteria
High FPG
High
triglycerides
Low HDL
cholesterol
High blood
pressure
Increased waist
circumference
ATP III (8)
Total 12.4 (11.4–13.4) 37.8 (36.0–39.5) 79.9 (78.2–81.6) 41.9 (40.1–43.5) 36.0 (34.7–37.4)
Men 13.3 (12.0–14.7) 40.1 (37.9–42.2) 75.9 (73.9–77.9) 39.6 (37.4–41.9) 16.5 (14.9–18.0)
Women 11.4 (9.9–12.9) 35.4 (33.0–37.7) 84.1 (81.8–86.3) 44.1 (41.9–46.3) 56.5 (54.3–58.6)
IDF (9)*–ATP III/AHA/NHLBI (10)
Total 15.7 (14.5–16.9) 37.8 (36.0–39.5) 79.9 (78.2–81.6) 41.9 (40.1–43.5) 54.9 (53.5–56.3)
Men 17.2 (15.7–18.6) 40.1 (37.9–42.2) 75.9 (73.9–77.9) 39.6 (37.4–41.9) 38.6 (36.6–40.7)
Women 14.2 (12.5–15.9) 35.4 (33.0–37.7) 84.1 (81.8–86.3) 44.1 (41.9–46.3) 71.9 (69.9–73.9)
Data are % (95% CI). *All components are similar in the IDF (9) and ATP III/AHA/NHLBI (10) deﬁnitions except the increased waist circumference that is the core
component of the IDF criteria.
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Eastern studies have been conducted at
the national level, and many target spe-
ciﬁc populations; hence, their ﬁndings
cannot be generalized to the region. A
study of female Saudi subjects found the
prevalence of metabolic syndrome to be
16.1 and 13.6% according to the IDF (9)
and ATP III (8) deﬁnitions, respectively
(16). In a population in Northern Jordan,
theprevalenceofthemetabolicsyndrome
(8) was reported to be 36.3%, with a sig-
niﬁcantly higher prevalence in women
than in men. The most common abnor-
mality was low HDL cholesterol in men
(62.7%) and increased waist circumfer-
ence in women (69.1%) (17). The preva-
lence of the metabolic syndrome (8) was
reportedtobe21.0%inonecityinOman,
with low HDL cholesterol (75.4%) and
increased waist circumference as the two
most common components (18).
The sex difference in the prevalence
ofthemetabolicsyndromeinthisstudyis
in line with that in previous studies in the
EMR (12–15,18) and local studies in Iran
(19,20). The prevalence of the metabolic
syndrome (8) in one of the studies in Iran
was reported to be 33.7%, with a higher
prevalence in women (42%) than in men
(24%) (19); the corresponding ﬁgure in
the other study was 23.3%, with a higher
prevalence in women (35.1%) than in
men (10.7%), respectively (20). The met-
abolic syndrome was documented in
about 75% of women aged 55–64 years;
this ﬁnding is alarming and conﬁrms the
theorythatmoreattentionshouldbepaid
topreventionandcontrolofthisdisorder,
which poses serious health threats.
In all of the aforementioned popula-
tion-basedstudiesintheMiddleEast(17–
20) as well as in this one, low HDL
cholesterol followed by abdominal obe-
sity has been the most common compo-
nentofthemetabolicsyndrome.Thehigh
prevalence of low HDL cholesterol, even
in many individuals without obesity and
hypertriglyceridemia, supports an ethnic
predisposition to this type of dyslipide-
mia. The ﬁndings in a recent study of the
strong association between migration of
Iranians to Sweden and the prevalence of
hypertension and smoking but not dys-
lipidemia (21) provide further conﬁrma-
tory evidence of the ethnic predisposition
to low HDL cholesterol. This ethnic pre-
disposition should be examined in future
genetic studies.
The IDF consensus strongly recom-
mends that ethnic group–speciﬁc cut
points for waist circumference should be
used; for the Eastern Mediterranean and
Middle Eastern populations, it is recom-
mended that the European cutoff points
ofwaistcircumferencebeuseduntilmore
speciﬁc data become available (9). In a
survey in Tunisia, a cutoff point of 85 cm
was documented for waist circumference
inbothsexes(22).AstudyinacityofIraq
showedwaistcircumferencecutoffpoints
of 97 cm in men and 99 cm in women
(23). In a study in Tehran, the cutoff
points for waist circumference were
80–93 cm for men and 79–96 cm for
women (24). The optimal cutoff points
obtainedfromthecurrentstudy(i.e.,89
cm for men and 91 cm for women) are
different from the Europid cutoff points
that are currently recommended for use
with Middle Eastern populations
(9,10).
Our ﬁnding of greater waist circum-
ference values in the Iranian community
than in Western populations may be
partlyduetoethnicdifferencesinbodyfat
patterning and the genetic tendency of
Asians to abdominal obesity (1); in addi-
tion,highcarbohydrateintakeandseden-
tary lifestyle in the Iranian community
might be contributing factors (20,25).
However, a recent study comparing el-
derly Iranians inside Iran with those set-
tled as migrants in Sweden showed the
prevalence of general obesity to be higher
in Iranian women in Sweden (42%) than
in Iran (34%), but abdominal obesity was
found in nearly 80% of women in both
groups (21). This ﬁnding suggests that
the role of ethnicity on increased waist
circumference might be more important
than lifestyle factors, a concept that needs
to be conﬁrmed by birth cohorts and
other longitudinal studies.
Study limitations and strengths
The main limitation of this study for de-
termining the optimal cutoff point for
waist circumference is its cross-sectional
nature; longitudinal studies are required
toconﬁrmourﬁndings.Furthermore,the
sensitivity and speciﬁcity of this cutoff
pointwerenothigh;however,itwouldbe
useful as a screening tool. The strength of
this study is its nationally representative
sample with valid weights for standard-
ization that enable us to infer with some
conﬁdence the distribution and epidemi-
ology of the metabolic syndrome and its
components in Iran and even in the
region.
In summary, the high prevalence of
the metabolic syndrome and its consider-
ableeffectonthemiddle-agedpopulation
mandate the implementation of national
policies for its prevention and control in
the Middle Eastern countries, which face
the world’s greatest increment in the ab-
solute burden of diabetes in the next two
decades. The cutoff points provided by
this survey can be used as optimal cutoff
points in the region.
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